Melanotan-1 (Afamelanotide)
Price Range
$2.80 – $4.40/mg
Vendors
11
Views
5
Where to Buy
Compare Melanotan-1 (Afamelanotide) prices across verified vendors. Affiliate links support Pushing Peptides.
| $4.00 | 10mg | $40.00 |
Price/mg
$4.00
Vial
10mg
Price
$40.00
| Vendor | Price/mg | Vial Size | Price/Vial | |
|---|---|---|---|---|
| $4.00 | 10mg | $40.00 | ||
| $4.40 | 10mg | $44.00 | ||
Instant PeptidesVerified | $4.00 | 10mg | $40.00 | View |
| $2.80 | 10mg | $27.95 | ||
| $3.50 | 10mg | $35.00 |
Price/mg
$4.00
Vial
10mg
Price
$40.00
Price/mg
$4.40
Vial
10mg
Price
$44.00
Price/mg
$2.80
Vial
10mg
Price
$27.95
Price/mg
$3.50
Vial
10mg
Price
$35.00
Overview
Melanotan-1 (Afamelanotide) is a synthetic linear analog of alpha-MSH with greater MC1R selectivity than Melanotan-2. This selectivity produces melanogenic effects (skin darkening) with significantly fewer off-target effects on sexual function and appetite compared to the broader-acting MT-2.
Mechanism of Action
Melanotan-1 selectively activates MC1R on melanocytes, stimulating eumelanin production. Eumelanin is the brown-black pigment that provides UV protection. The targeted MC1R activation avoids significant CNS effects (sexual arousal, appetite changes) associated with MC3R/MC4R/MC5R activation seen with MT-2.
Research Context
Afamelanotide has been approved in Europe (as Scenesse) for erythropoietic protoporphyria, a condition where patients cannot tolerate sunlight. Research continues into photoprotection, vitiligo, and skin cancer prevention applications.
Key Research Areas
Considerations for Researchers
More selective than MT-2 with fewer side effects. Store lyophilized at -20C protected from light. Reconstituted solutions should also be light-protected.
Disclaimer: All information on this page is for research purposes only and is not intended as medical advice. Peptide research should be conducted by qualified professionals in appropriate laboratory settings. Pushing Peptides does not sell peptides. We aggregate publicly available pricing and vendor data.